What FSH (Follicle-Stimulating Hormone) levels suggest azoospermia versus oligospermia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FSH Levels in Azoospermia vs. Oligospermia

FSH levels greater than 7.6 IU/L strongly suggest non-obstructive azoospermia, while FSH levels less than 7.6 IU/L typically indicate obstructive azoospermia or oligospermia. 1

Diagnostic Patterns

Azoospermia

  • Non-obstructive azoospermia (NOA):

    • FSH levels typically elevated above 7.6 IU/L 1
    • Associated with testicular atrophy on physical examination 2
    • Normal semen volume and pH 2
    • Indicates primary testicular dysfunction or hypothalamic-pituitary-gonadal axis dysfunction 1
  • Obstructive azoospermia:

    • FSH levels usually less than 7.6 IU/L 1
    • Normal testicular size and consistency 1
    • Often presents with low ejaculate volume (<1.4 mL) and acidic semen (pH <7.0) 1
    • May be associated with congenital bilateral absence of vas deferens or ejaculatory duct obstruction 1

Oligospermia

  • Severe oligospermia (<5 million sperm/mL):

    • May have elevated FSH, but typically lower than in non-obstructive azoospermia 1, 3
    • FSH levels correlate inversely with sperm concentration 3
    • Requires genetic testing when accompanied by elevated FSH and testicular atrophy 1
  • Moderate to mild oligospermia (5-15 million sperm/mL):

    • FSH levels may be normal or slightly elevated 4, 3
    • Less likely to have Y-chromosome microdeletions (only 0.8% in men with >1-5 million sperm/mL) 1

Clinical Implications

  • FSH elevation correlates with the appearance of Sertoli cell only (SCO) tubules 5:

    • Mixed atrophy with unilateral focal SCO: FSH ~7.4 IU/L 5
    • Mixed atrophy with bilateral focal SCO: FSH ~10.7 IU/L 5
    • Bilateral or unilateral total SCO: FSH ~16.0 IU/L 5
  • Normal FSH does not exclude severe spermatogenic dysfunction in all cases 5:

    • Some men with maturation arrest on histology can have normal FSH despite severe spermatogenic dysfunction 6
    • Therefore, FSH alone cannot definitively predict sperm retrieval success in all cases 6

Diagnostic Algorithm

  1. Perform semen analysis with centrifugation to confirm azoospermia or determine degree of oligospermia 1, 6

  2. Measure FSH levels:

    • If FSH >7.6 IU/L with testicular atrophy: Likely non-obstructive azoospermia 1
    • If FSH <7.6 IU/L with normal testicular size: Consider obstructive azoospermia or mild oligospermia 1
    • If FSH is borderline (around 7.6 IU/L): Additional testing needed 5
  3. Additional testing based on FSH results:

    • For elevated FSH: Recommend karyotype testing and Y-chromosome microdeletion analysis 1
    • For normal FSH with azoospermia: Consider evaluation for obstruction 1

Important Caveats

  • Confirmation of azoospermia requires centrifugation of the ejaculate and examination of the pellet under microscopy 1
  • Complete AZFa and AZFb Y-chromosome microdeletions result in almost zero likelihood of sperm retrieval 1
  • Hormonal levels (FSH, LH, inhibin B, AMH) have variable correlation with sperm retrieval outcomes in NOA 1
  • FSH bioactivity may differ from immunoreactive FSH levels in some infertile men, though this is not routinely tested in clinical practice 4, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Obstructive Azoospermia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated FSH with Low Sperm Count or Azoospermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.